Photoreceptor system for melatonin regulation and phototherapy
Abstract
The present invention involves a light system for stimulating or regulating neuroendocrine, circadian, and photoneural systems in mammals based upon the discovery of peak sensitivity ranging from 425-505 nm; a light meter system for quantifying light which stimulates or regulates mammalian circadian, photoneural, and neuroendocrine systems. The present invention also relates to translucent and transparent materials, and lamps or other light sources with or without filters capable of stimulating or regulating neuroendocrine, circadian, and photoneural systems in mammals. Additionally, the present invention involves treatment of mammals with a wide variety of disorders or deficits, including light responsive disorders, eating disorders, menstrual cycle disorders, non-specific alerting and performance deficits, hormone-sensitive cancers, and cardiovascular disorders.
Claims
exact text as granted — not AI-modified1 - 8 . (canceled)
9 . A system for measuring optical radiation, comprising:
a meter configured to measure lux corresponding to a spectral sensitivity of a photoreceptor system for at least one of a circadian, photoneural or neuroendocrine systems in a mammal,
wherein said lux includes at least one peak within the range of 425-505 nm,
wherein said meter is configured to measure the therapeutically effective levels of said lux; and
means for stimulating the photoreceptor system to treat or prevent a light responsive disorder in said mammal.Join the waitlist — get patent alerts
Track US2013261707A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.